BT Lab
SKU:BT-AP06068
NM23-H2 Polyclonal Antibody
NM23-H2 Polyclonal Antibody
Couldn't load pickup availability
Nucleoside diphosphate kinase (NDK) exists as a hexamer composed of ‘A' (encoded by NME1) and ‘B' (encoded by this gene) isoforms. Multiple alternatively spliced transcript variants have been found for this gene. Read-through transcription from the neighboring upstream gene (NME1) generates naturally-occurring transcripts (NME1-NME2) that encode a fusion protein comprised of sequence sharing identity with each individual gene product.
The NM23-H2 Polyclonal Antibody is a highly specific and sensitive tool for the detection and analysis of NM23-H2 protein expression. This antibody has been rigorously tested and validated for use in various applications, including Western blotting, immunohistochemistry, and immunofluorescence.
The NM23-H2 Polyclonal Antibody is produced using state-of-the-art techniques, ensuring high purity and quality. It exhibits excellent specificity, binding only to the NM23-H2 protein and not cross-reacting with other related proteins. This specificity allows for accurate and reliable results, minimizing false positives and false negatives.
With its high sensitivity, the NM23-H2 Polyclonal Antibody can detect even low levels of NM23-H2 protein expression. This makes it an ideal tool for studying the expression patterns and localization of NM23-H2 in various tissues and cell types. Its versatility allows for a wide range of applications, making it suitable for use in both basic research and clinical diagnostics.
The NM23-H2 Polyclonal Antibody is supplied in a convenient and ready-to-use format, eliminating the need for time-consuming and complex preparation steps. It is available in various sizes to meet the specific needs of different experiments and applications.
In summary, the NM23-H2 Polyclonal Antibody is a reliable and efficient tool for the detection and analysis of NM23-H2 protein expression. Its high specificity, sensitivity, and versatility make it an invaluable asset for researchers and clinicians alike.
Share
